SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-002370
Filing Date
2015-01-14
Accepted
2015-01-14 16:16:20
Documents
11
Period of Report
2014-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a14-25963_110q.htm 10-Q 340624
2 EX-31.1 a14-25963_1ex31d1.htm EX-31.1 10792
3 EX-31.2 a14-25963_1ex31d2.htm EX-31.2 10764
4 EX-32.1 a14-25963_1ex32d1.htm EX-32.1 6257
5 EX-32.2 a14-25963_1ex32d2.htm EX-32.2 6238
  Complete submission text file 0001104659-15-002370.txt   1625756

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20141130.xml EX-101.INS 152075
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20141130.xsd EX-101.SCH 15903
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20141130_cal.xml EX-101.CAL 15878
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20141130_def.xml EX-101.DEF 25797
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20141130_lab.xml EX-101.LAB 139382
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20141130_pre.xml EX-101.PRE 85860
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 15527384
SIC: 2835 In Vitro & In Vivo Diagnostic Substances